LexDanaLexDanabeta
Inventor

MARSHALL L. GRANT

Inventor
US

Overview

3→
Patents
2021–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07DHeterocyclic compounds21%
A61MDevices for introducing media into, or onto, the body14%
Y10TTechnical subjects covered by former us classification14%
B01DSeparation7%
PatentTitleYear
12,383,552Diketopiperazine microparticles with defined specific surface areas202511,607,410Diketopiperazine microparticles with defined specific surface areas202311,192,862Microcrystalline diketopiperazine compositions and methods2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2025Patents assigned to MANNKIND CORP (3)· patent assignee history
2021–2025Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MANNKIND CORP32021–2025
Locations
LocationPatentsSpan
US32021–2025